Company intelligence / Profile preview

Cell Signaling Technology

Danvers, Massachusetts, United Statescellsignal.com ↗

Ownership: Private
Employees: ~600
Development stage: Other

Overview

CST does not have clinical results as it supplies reagents and technologies to the life sciences community rather than developing drugs.

Therapeutic areas: Other
Modalities: AntibodyRecombinant proteinPeptidesELISA kit (as a research tool)Proteomics analytical services
Industry: Non-Drug Biotech

Partnerships

No major pharma/biotech partnerships publicly listed; collaborates with academic institutions via PhosphoSitePlus® and supports global scientific community.

Beyond the preview

Go deeper on Cell Signaling Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Signaling Technology.